October 19th, 2026AAO 2026: Rethinking dry eye as a spectrum of ocular painAnat Galor, MD, MSPH, discusses subtyping dry eye, emerging diagnostic tools, and when to consider oral neuromodulation.Read more
October 30th, 2026Lambert-Eaton Myasthenic Syndrome: how eye care professionals differentiate it from myasthenia gravisLambert-Eaton myasthenic syndrome is a rare autoimmune disorder of the neuromuscular junction that should be differentiated from myasthenia gravis, another neuromuscular junction disorder. Read more
October 26th, 2026Women’s Health: Identifying dry eye in rheumatoid arthritis can make all the differenceRheumatoid arthritis, is an autoimmune disorder, develops more often in women than men in a 3:1 ratio. Read more
October 30th, 2026OT Roundup: 3 FDA approvals, vorolanib insert miss, brepocitinib in uveitisVeeral Sheth, MD, breaks down the LUCIA wet AMD data, plus new AAO findings on GLP-1 agents and anti-VEGF treatment burden in DME.Read more
October 29th, 2026Matching patients to PRK, LASIK, SMILE, or phakic IOLsIsa S. K. Mohammed, MD, explains how he matches patients to PRK, LASIK, SMILE, or phakic IOLs and how prior surgery affects IOLs.Read more
October 24th, 2026AAO 2026: GLP-1RA initiation not linked to anti-VEGF burden in DMEIRIS Registry data showed no change in anti-VEGF frequency, vision, or retinal thickness after patients with DME began a GLP-1RA.Read more
October 22nd, 2026Murtaza K. Adam, MD, on pearls for the Yamane scleral-fixated IOL techniqueMurtaza K. Adam, MD, shares pearls on haptic docking, patient selection, and preventing complications with the Yamane technique.Read more
October 20th, 2026NeuroOp Guru at AAO 2026: Blurry vision in MS isn’t always a relapseAndrew G. Lee, MD, and Drew Carey, MD, break down the link between optic neuritis and uveitis in central nervous system demyelinating disease.Read more